Mimio
Summary
Mimio Health is pioneering the first supplement designed to mimic the metabolic effects of fasting without requiring dietary restrictions. Rooted in cutting-edge metabolomics research, Mimio’s formulation is based on bioactive fasting metabolites identified through extensive screening and validation. Studies have shown that Mimio’s approach enhances cellular antioxidant capacity by up to 3x, reduces inflammation by 10x, and extends lifespan in model organisms
Investors
Team
Chris Rhodes Co-founder and CEO
Dr. Chris Rhodes is the co-founder and CEO of Mimio Health, a company pioneering biomimetic supplements that replicate the benefits of fasting. He earned his Ph.D. in Nutritional Biochemistry from the University of California, Davis, where he led clinical research on human fasting, identifying key bioactive metabolites that enhance cellular health and longevity. Transitioning from research to entrepreneurship, Dr. Rhodes co-founded Mimio Health to commercialize these findings, with support from programs like UC Davis’s Venture Catalyst and IndieBio.
Angela Zivkovic Co-founder
Dr. Angela M. Zivkovic is an Associate Professor in the Department of Nutrition at the University of California, Davis, and a co-founder of Mimio Health. She obtained her Ph.D. in Nutritional Biology from UC Davis and has dedicated her research to precision health, focusing on how diet and nutrition can be tailored to optimize health and prevent disease. Her work encompasses investigating the functional biology of high-density lipoprotein (HDL), the impact of diets on inflammation, and the interplay between diet, the gut microbiome, and host health. In recognition of her exemplary work, she was named a Chancellor’s Fellow at UC Davis in 2024.
